ECPI Pharm Final Exam Questions with
Correct Answers
noncompliance - Answer-An informed decision on the part of the patient not to adhere
to or follow a therapeutic plan or suggestion.
compliance - Answer-Implementation or fulfillment of a prescriber's/ caregiver's
prescribed course of treatment or therapeutic plan by a patient. Use of compliance
versus the term adherence acknowledges the consideration/acceptance of
patient/family/caregiver participation in the use of the nursing process.
subjective data - Answer-all spoken information shared by the patient, such as
complaints, problems, or stated needs (e.g., patient complains of "dizziness, headache,
vomiting, and feeling hot for 10 days").
objective data - Answer-information available through the senses, such as what is seen,
felt, heard, and smelled. Among the sources of data are the medical record, laboratory
test results, reports of diagnostic procedures, physical assess-ment, and examination
findings. Examples of specific data are age, height, weight, allergies, medication profile,
and health history.
liver - Answer-primary job is to metabolize medication
adverse drug reaction - Answer-Any unexpected, unintended, undesired, or excessive
response to a medication given at therapeutic dosages (as opposed to overdose).
allergic reaction - Answer-An immunologic hypersensitivity reaction resulting from the
unusual sensitivity of a patient to a particular medication; a type of adverse drug event.
blood brain barrier - Answer-The barrier system that restricts the passage of various
chemicals and microscopic entities (e.g., bacteria, viruses) between the bloodstream
and the central nervous system. It still allows for the passage of essential substances
such as oxygen
contraindication - Answer-Any condition, especially one related to a disease state or
patient characteristic, including current or recent drug therapy, which renders a
particular form of treatment improper or undesirable
drug - Answer-Any chemical that affects the physiologic processes of a living organism.
first pass effect - Answer-The initial metabolism in the liver of a drug absorbed from the
gastrointestinal tract before the drug reaches systemic circulation through the
bloodstream.
, generic name - Answer-The name given to a drug by the United States Adopted Names
Council. Also called the nonproprietary name. The generic name is much shorter and
simpler than the chemical name and is not protected by trademark.
parental/ IV route - Answer-fastest route, quicker absorption
pharmacokinetics - Answer-involve ingestion, excretion, metabolism, and absorption
excretion - Answer-kidney failure patients will have a challenge with this
absorption definition - Answer-the process of being absorbed, for nourishment
purposes. takes places in the stomach and small intestine
absorption - Answer-patients with gastric and bowels issues struggle with this
subcutaneous - Answer-injected into the fatty layer under the dermal layer
slower absorption rate, due to lack of vascular
half-life - Answer-In pharmacokinetics, the time required for half of an administered
dose of drug to be eliminated by the body, or the time it takes for the blood level of a
drug to be reduced by 50% (also called elimination half-life
sublingual route - Answer-administration of medication by placing it under the tongue
and allowing it to dissolve slowly
skin layers - Answer-epidermis: transdermal patch, intradermal injection slow absorption
rate
dermis: intradermal infejection
subcutaneous: subcu- injection
Beer's list - Answer-identifies drugs with a high likelihood of causing adverse effects in
older adults
neonate patient - Answer-Pertaining to a person younger than 1 month of age; newborn
infant.
infant patient - Answer-between 1 and 12 months of age
informed consent - Answer-Written permission obtained from a patient consenting to a
specific procedure.
ethnopharmacology - Answer-The study of the effect of ethnicity on drug responses,
specifically drug absorption, metabolism, distribution, and excretion as well as the study
of genetic variations to drugs (i.e., pharmacogenetics)